Vertex Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
01.02.24
/
50%
€400.30
Target price
01.02.25
€404.41
Performance (%)
14.39%
Price
18:24
€457.90
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ currently has a performance of 14.39%. This prediction currently runs until 01.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | 1.444% | 1.444% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at JPMorgan Chase & Co. from $390.00 to $438.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat